Magnevie B6

Magnesium, Pyridoxine Hydrochloride, the active ingredient in Magnevie B6, is a dietary supplement presented as an oral dosage form for oral use. It supports normal magnesium and vitamin B6 levels, contributing to muscle, nerve and metabolic health in adults.

GNH USA supplies Magnevie B6 as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Magnevie B6, a combined magnesium and vitamin B6 supplement, supports metabolic and nervous system health.

- Magnesium deficiency: helps restore normal magnesium levels and reduce related symptoms such as muscle cramps. - Vitamin B6 deficiency: contributes to normal amino acid metabolism and alleviates deficiency manifestations. - General muscle function: supports normal muscle contraction and relaxation. - Nervous system function: aids in the synthesis of neurotransmitters for normal nervous system activity.

Magnevie B6 may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Diarrhea: loose stools occurring after oral intake. - Nausea: mild stomach upset or queasiness. - Abdominal discomfort: cramping or bloating. - Headache: transient mild headache.

Serious or Rare Side Effects: - Hypermagnesemia: elevated serum magnesium, potentially causing cardiac arrhythmia. - Allergic reaction: rash, itching, swelling of face or throat. - Anaphylaxis: severe, rapid‑onset allergic response requiring emergency care.

When using Magnevie B6, consider the following safety measures. - Assess renal function: impaired kidneys may reduce magnesium clearance. - Avoid excessive intake: high doses can lead to hypermagnesemia. - Monitor drug interactions: concurrent antibiotics or bisphosphonates may affect absorption. - Pregnancy and lactation: use only if prescribed by a healthcare professional. - Children: dosage must be determined by a qualified practitioner. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Magnevie B6 can affect the absorption or activity of several medicines.

Major Interactions (Avoid): - Tetracycline antibiotics: magnesium chelates reduce oral absorption. - Fluoroquinolone antibiotics: similar chelation decreases bioavailability. - Bisphosphonates: magnesium interferes with gastrointestinal uptake.

Moderate Interactions (Monitor Closely): - Loop and thiazide diuretics: may increase urinary magnesium loss. - Cardiac glycosides: magnesium can potentiate their effects on cardiac conduction. - Anticonvulsants (e.g., phenytoin): vitamin B6 status influences drug metabolism.